Saccharomyces boulardii is one of the most researched probiotic yeasts, prized for its ability to support gut barrier function, reduce diarrhea, and modulate inflammation. Yet when consumers reach for a bottle, they rarely ask the one question that matters most: does this strain carry the specific designation CNCM I-745?
The answer separates generic products from those with decades of clinical validation. CNCM I-745 (also known as Saccharomyces boulardii CNCM I-745) is the exact strain used in landmark studies on antibiotic-associated diarrhea, traveler’s diarrhea, and inflammatory bowel conditions. Most brands simply list “S. boulardii” without specifying the strain, leaving users to assume equivalence where none exists.
Why Strain Specificity Matters for S. Boulardii
Not all S. boulardii are created equal. Genetic sequencing shows meaningful differences in survival through gastric acid, adhesion to intestinal mucosa, and secretion of protective proteins. CNCM I-745 has been deposited in the Collection Nationale de Cultures de Microorganismes in France and subjected to rigorous genomic and functional characterization.
This strain produces unique proteases that degrade bacterial toxins, stimulates brush-border enzymes, and upregulates tight-junction proteins. These mechanisms explain its consistent performance in randomized controlled trials. Generic strains often lack the same level of toxin-binding capacity or fail to colonize transiently with the same reliability.
Consumers mistakenly believe any “S. boulardii” product will deliver identical results. In reality, many supermarket and even practitioner brands use cheaper, less-characterized isolates. Without the CNCM I-745 identifier on the label or certificate of analysis, there is no guarantee the product matches the researched strain.
Popular Brands: Which Actually Use CNCM I-745?
Florastor remains the gold standard. Every capsule and sachet contains the exact CNCM I-745 strain at a clinically validated dose of 250 mg (approximately 5 billion CFU). The manufacturer transparently lists the strain on every package and in its technical data.
Several other reputable brands also use CNCM I-745 under license. These include select formulations from Biocodex (the original developer), certain European pharmacy exclusives, and a handful of professional-line supplements that explicitly state “S. boulardii CNCM I-745” on the Supplement Facts panel. Always verify the strain name rather than relying on marketing claims like “clinically studied” or “original strain.”
Conversely, many best-selling Amazon and health-store products list only “Saccharomyces boulardii” or “S. boulardii DBVPG 6763.” These designations refer to different deposits with distinct properties. While they may offer general probiotic support, they cannot claim the same depth of published evidence as CNCM I-745.
Common Mistakes Consumers and Practitioners Make
The biggest error is assuming higher CFU counts compensate for an uncharacterized strain. A product boasting 20 billion CFU of an unspecified S. boulardii may underperform compared with 5 billion CFU of the documented CNCM I-745. Potency without proven strain identity is marketing, not medicine.
Another frequent misstep is ignoring storage requirements. Although S. boulardii is more resilient than many bacterial probiotics, CNCM I-745 performs best when protected from excessive heat and moisture. Refrigeration is not always required, but keeping bottles below 77 °F (25 °C) and away from bathroom humidity preserves viability.
Label reading habits also mislead. Terms such as “lyophilized,” “delayed-release,” or “with prebiotics” sound impressive yet reveal nothing about strain identity. The only reliable markers are the precise alphanumeric code CNCM I-745 or the older synonym SB 745.
Practitioners sometimes compound the problem by recommending “any S. boulardii” for patients on antibiotics or traveling. Without strain specificity, outcomes become unpredictable. Patients may experience no benefit or, worse, assume probiotics “don’t work” when the real issue was an unverified product.
How to Verify and Choose the Right S. Boulardii Product
First, demand transparency. Reputable manufacturers list the exact strain on the label or provide a certificate of analysis upon request. If the brand cannot or will not confirm CNCM I-745, choose another.
Second, look for third-party testing. Independent labs can confirm both identity via DNA sequencing and viable cell count at expiry. Certificates should be current and product-specific rather than generic.
Third, match the dose to the indication. Clinical trials demonstrating efficacy for acute diarrhea typically use 250–500 mg (5–10 billion CFU) of CNCM I-745 daily. Maintenance or preventive protocols may use lower doses, but consistency matters more than megadosing an unverified strain.
Finally, consider synergies. CNCM I-745 works well alongside specific bacterial strains such as Lactobacillus rhamnosus GG or certain Bifidobacterium species, but avoid products that combine dozens of organisms at trace levels. Multi-strain formulas can dilute the proven benefits of the yeast.
Beyond the Strain: Integrating S. Boulardii into a Broader Gut Protocol
While strain identity is foundational, optimal results require context. Pairing CNCM I-745 with an anti-inflammatory, nutrient-dense diet enhances its ability to restore intestinal homeostasis. Supporting mitochondrial efficiency through adequate protein, resistance training, and targeted micronutrients further amplifies gut–metabolism crosstalk.
For individuals working on metabolic reset protocols, S. boulardii CNCM I-745 can help stabilize the microbiome during dietary transitions, reducing the risk of rebound inflammation that undermines leptin sensitivity and GLP-1 signaling. Its gentle action makes it suitable during both aggressive loss phases and long-term maintenance.
Ultimately, the question is not whether S. boulardii works—it is whether the specific product in your hand contains the strain that has been proven to work. By insisting on CNCM I-745 and avoiding the common pitfalls of generic labeling, practitioners and health-conscious consumers can harness one of the most reliable tools in functional gut health.
Choosing wisely transforms a simple yeast into a clinically grounded ally for digestion, immunity, and metabolic resilience.